Comparison of Efficacy of Pirubicin and Gemcitabine in Hyperthermic In-travesical Perfusion Chemotherapy in Patients Undergoing Surgery for Su-perficial Bladder Cancer

SUN Qingfeng; QIU Xiaoyu; TIAN Longjiang

doi:10.3969/j.issn.2095-3097.2023.03.006

Home>Articles>Comparison of Efficacy of Pirubicin and Gemcitabine in Hyperthermic In-travesical Perfusion Chemotherapy in Patients Undergoing Surgery for Su-perficial Bladder Cancer

DOI: 10.3969/j.issn.2095-3097.2023.03.006

Comparison of Efficacy of Pirubicin and Gemcitabine in Hyperthermic In-travesical Perfusion Chemotherapy in Patients Undergoing Surgery for Su-perficial Bladder Cancer

SUN Qingfeng

QIU Xiaoyu

TIAN Longjiang

Keywords：Urinary bladder neoplasmsSuperficial bladder cancerPirarubicinGemcitabineChemotherapycancerregional perfusionVascular endothelial growth factorCarcinoembryonic antigenOverall survival

Publication Date：2023-06-20

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 157-161,172 )

Translational Medicine Journal

ISTIC

ISSN：2095-3097

Year, Vol.(Issue)：2023,12(3)